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Besides the hypothalamus and pituitary, melatonin action at 
the testicular level has been recently suggested. Therefore, we 
investigated in the Syrian hamster, a well-characterized sea­
sonal breeder, melatonin action on Leydig cells, testicular 
expression of melatonergic receptors, and possible interac­
tions between melatonin receptors and the previously iden­
tified testicular serotoninergic and CRH systems. In isolated 
Leydig cells from active testes of adult hamsters kept in a 
long-day (14 h light, 10 h dark) photoperiod and from re­
gressed testes of adult animals exposed to a short-day photo­
period during 16 wk (6 h light, 18 h dark), melatonin signifi­
cantly reduced human chorionic gonadotropin-stimulated 
production of cAMP and the main androgens: testosterone 
and androstane-3a,17/J-diol, respectively, and decreased the 
expression of steroidogenic acute regulatory protein, P450 
side chain cleavage, 3/J-hydr oxy steroid dehydrogenase and 
17/1-hydroxysteroid dehydrogenase. In Leydig cells exposed 
to a short-day photoperiod during 16 wk, melatonin stimu-
THE PINEAL HORMONE melatonin plays a key role mediating the influence of photoperiod on the re­production of many mammalian species. The duration of 
daily melatonin secretion is negatively correlated with the 
time the seasonal animal is exposed to daylight. Light 
signals are received by the photoreceptors of the retina. 
Therefore, the neural information is transferred from the 
eyes to the pineal gland through a circuitous connection of 
neurons involving retinohypothalamic fibers, the supra- 
chiasmatic nuclei, hypothalamus-pineal fibers, and the pe-
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lated the conversion of testosterone into 5a-reduced andro­
gens by inducing 5a-reductase isoform 1, and controlled 
androstane-3a,17/J-diol production by inhibiting 3a-hydroxy- 
steroid dehydrogenase expression. Melatonin subtype (mella) 
receptors were detected in Leydig cells. Although the local 
serotonin system did not mediate melatonin action on andro­
gen production, melatonergic effect on steroidogenesis in­
volved the interaction between mella receptors and the in­
hibitory CRH system. Moreover, melatonin significantly 
increased CRH mRNA levels and production in hamster Ley­
dig cells expressing CRH subtype 1 receptors. Our studies 
indicate that melatonin may act as a local inhibitor of human 
chorionic gonadotropin-stimulated cAMP and androgen pro­
duction through mella receptors, down-regulation of steroi­
dogenic acute regulatory protein, and key steroidogenic en­
zymes expression and its interaction with the local CRH 
system. (Endocrinology 146: 1541-1552, 2005)
ripheral sympathetic nervous system, resulting in the sup­
pression of melatonin synthesis (1-3). Interruption of the 
neural pathways anywhere between the suprachiasmatic 
nuclei and the pineal turns this gland nonfunctional in 
terms of its capacity to alter the reproductive system (2,4). 
Melatonin exerts its effects via specific receptors. Melato­
nin receptors, which are coupled to G protein and char­
acterized by a seven transmembrane-spanning domain, 
were initially classified as ML1 and ML2 subtypes by 
Dubocovich et al. (5), based on pharmacological and ki­
netic differences. Recent cloning studies identified three 
subtypes of ML1 receptors: melatonin subtype (mel)la 
receptors (also known as ML1A or mtj, which are ex­
pressed in the suprachiasmatic nucleus of the hypothal­
amus and pars tuberalis of the pituitary (6, 7); mellb 
receptors (also known as ML1B or MT2), which are ex­
pressed in brain and retina (5, 8); and mellc receptors, 
which are not expressed in mammals but were found in 
Xenopus, chicken, and Zebra fish (9).
Melatonin is a transducer of the photoperiodic infor­
mation that, acting mainly at the level of the brain and 
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light signal is interpreted as anti- or progonadotropic will 
depend on the species (long-day seasonal breeders includ­
ing the hamsters, short-day seasonal breeders such as 
sheep, or nonseasonal breeders like humans), the duration 
of night melatonin peak (the duration hypothesis), the 
magnitude of the night melatonin peak (the amplitude 
hypothesis), and/or the window of sensitivity to melato­
nin (the internal coincidence hypothesis) (10-13). The in­
ternal coincidence model is of interest because it has been 
proposed to explain a significant aspect of the seasonal 
reproductive cycle in the Syrian hamster. After long pe­
riods of short daylight, gonads of the Syrian hamster un­
dergo spontaneous or endogenous recrudescence either in 
the total absence of light or under short-day conditions. 
Even when circulating levels of melatonin are high, the 
neuroendocrine-reproductive system merely ignores the 
message, perhaps as a consequence of the lack of coinci­
dence between the high levels of melatonin and the mel­
atonin sensitivity period of the reproductive system (13).
Thus, through the hypothalamic suprachiasmatic nucleus 
and the pars tuberalis, melatonin influences the synthesis 
and release of the hypothalamic GnRH and the adenohy- 
pophyseal gonadotropin hormones. Nevertheless, it has also 
been described that newly synthesized melatonin, which is 
released from the pineal gland into the circulation almost 
entirely at night, reaches peripheral tissues including the 
testes (13-15). New evidence suggests the existence of a local 
synthesis of melatonin in testes (16-19). In this context, it is 
important to mention previous studies describing melatonin 
action at gonadal level including the regulation of testicular 
growth, cAMP production, and testosterone production (20- 
22). In addition, 2-[125I]iodomelatonin binding sites have 
been detected in rat and avian testes (23-25).
The Syrian hamster (Mesocricetus auratus) is a thoroughly 
studied seasonal breeder and, consequently, a useful model 
for investigating the role played by melatonin in the regu­
lation of the reproductive function (26). In the present study, 
adult Syrian hamsters were either maintained in a long-day 
(LD, 14 h light, 10 h dark) photoperiod or exposed to a 
short-day photoperiod for 16 wk (16SD, 6 h light, 18 h dark) 
to reach the maximal testicular regression. This stage is ac­
companied by a marked decrease in serum levels of FSH, LH, 
and prolactin and a decline in blood and gonadal concen­
trations of testosterone, its hormonal precursors, and its me­
tabolites (26-29). The specific aims of this study were: 1) to 
examine the role of melatonin on in vitro cAMP and androgen 
production from purified Leydig cells; 2) to analyze the ac­
tion of melatonin on the androgen biosynthetic pathway, 
namely steroidogenic enzymes gene expression; and 3) to 
identify the presence of testicular melatonin receptors sub­
types (mella, mellb) in both LD and 16SD hamster testes.
Because interactions between the testicular serotonergic 
and CRH systems leading to the regulation of androgen 
production have been previously described (30-32), we pro­
posed to examine whether the melatonergic system interacts 
with the serotonergic and/or CRH systems in hamster Ley­




Male Syrian hamsters (M. auratus) were raised in our animal care unit 
(Charles River descendants, Animal Care Laboratory, Instituto de Bio­
logía y Medicina Experimental, Buenos Aires). Hamsters were kept in 
rooms at 23 ± 2 C and maintained from birth in LD (14 h light, 10 h dark; 
lights on 0700-2100 h) photoperiod. Animals had free access to water 
and Purina formula chow. For the present study, several groups of 12 
adult hamsters (90-100 d) were kept under LD conditions for 16 wk or 
transferred to a SD photoperiod (6 h light, 18 h dark; lights on 0900-1500 
h) for 16 wk. It is important to mention that hamsters from our colony 
reach the maximal gonadal regression after 16 wk of SD photoperiod [see 
additional information in Frungieri etal. (29)]. Then hamsters were killed 
by asphyxia with carbon dioxide (CO2) according to protocols for animal 
use, approved by the Institutional Animal Care and Use Committee 
(Instituto de Biología y Medicina Experimental-Consejo Nacional de 
Investigaciones Científicas y Técnicas) following National Institutes of 
Health guidelines. At the time of killing, testicular weight and testos­
terone circulating levels were determined as follows (means ± sem): 
testicular weight = 1.75 ± 0.16 g and 0.16 ± 0.09 g (n = 24), testosterone 
levels = 20.49 ± 0.94 pmol/ml, and 3.26 ± 0.69 pmol/ml (n = 24) for 
LD and 16SD hamsters, respectively.
For RT-PCR and Western blotting studies, testes were rapidly re­
moved and frozen at —80 C until assays were performed.
In other groups of animals, testes were dissected and used for Leydig 
cells purification. Then Leydig cells were employed for hi vitro incuba­
tions and subsequent determination of mRNA (by RT-PCR) and protein 
(Western blotting) expression for measurement of intracellular CRH 
concentration by enzyme immunoassay (EIA) or quantification of cAMP 
and androgens levels in the incubation media by RIA.
Hamster Leydig cells purification and in vitro incubations
In all experiments, Leydig cells were isolated from a pool of 24 testes 
obtained from 12 adult hamsters (90-100 d of age) maintained in LD 
photoperiod for 16 wk or exposed to a 16SD. Leydig cells were isolated 
under sterile conditions using a discontinuous Percoll density gradient 
as previously described by Frungieri et al. (32). Cells that migrated to the 
1.06-1.12 g/ml density fraction were collected and suspended in me­
dium 199. An aliquot was incubated for 5 min with 0.4% Trypan blue 
and used for cell counting and viability assay in a light microscope. 
Viability of Leydig cells preparations was 97.5-98.5%. To evaluate en­
richment in Leydig cells, the activity of 3/3-hydroxysteroid dehydroge­
nase was measured as previously described Levy et al. (33). Cell prep­
arations were 85-90% enriched with hamster Leydig cells. Petri dishes 
with 1.5 ml medium 199 containing 2.5 x 105 cells (for RT-PCR, in vitro 
cAMP and androgen production) or 3.0 x 106 cells (for determination 
of CRH concentration) were incubated at 37 C under a humid atmo­
sphere of 5% CO2 ill presence of 0.1 inM 3-isobutyl-l-methylxanthine, a 
phosphodiesterase inhibitor (Sigma Chemical, St. Louis, MO) and in 
presence or absence of the following chemicals: 100 mlU/ml human 
chorionic gonadotropin (hCG) (Ayerst, Princeton, NJ; specific activity, 
59 IU/mg), 10 pM to 1 melatonin (Sigma), 1 luzindole (Sigma), 
1 CRH (Sigma), 1 CRH receptor antagonist (a-helical CRH-19- 
41]; Peninsula Laboratories, Belmont, CA), 1 |.i\f (±)l-[2,5-dimethoxy- 
4-iodophyryl]-2-amino propane hydrochloride (Biochemicals, Inc., 
Wayland, MA), 1 ketanserin tartrate (Biochemicals), 1 metoclo­
pramide hydrochloride (Biochemicals), 1 |.i\f 4-iodo-N-[2-[4-(methoxy- 
phenyl)-l-piperazinyl] ethyl]-N-2-pyridinyl-benzamide hydrochloride 
(y-MIT’l; Biochemicals), and 1 (±) 8-hydroxy-2(Dl-N-propylamino)
tetralin hydrobromide (Biochemicals).
Luzindole stock solution was prepared in ethanol and consequently, 
for those experiments in which luzindole effect was tested, control 
incubations received the same vehicle (ethanol) as treated cells. Other 
chemicals listed above were dissolved in medium 199. After 30 min (for 
semiquantitative RT-PCR assays) or 3 h incubation (for determination of 
cAMP, androgens, and CRH levels), cells in the incubation media were 
transferred to tubes and centrifuged at 1200 x g for 10 min. No evidence 
of morphological changes was detected when microscopic studies of 
cellular morphology were performed in hamster Leydig cells after in­
cubation with the drugs previously mentioned. Cells were used for RNA 
extraction and RT-PCR or for CRH quantification by EIA. Media were 
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frozen at —20 C until androgens concentrations and cAMP levels were 
determined by RIA.
RT-PCR analysis
RNA was extracted from total testicular tissue or isolated Leydig cells 
from adult hamsters kept under LD conditions for 16 wk or exposed to 
a 16SD photoperiod using the Purescript kit (Biozym, Hessisch Olden­
burg, Germany). Then reverse transcription reaction using oligo dT15 
primers followed by PCR amplification was performed (34). Commer­
cial cDNAs from reverse transcribed human testicular mRNA (pooled 
from 19 men; Clontech Inc., Palo Alto, CA; one sample from Invitrogen, 
Karlsruhe, Germany) were also used for PCR amplification. Information 
about oligonucleotide primers employed and cDNAs isolated are given 
in Table 1. When information about exon structure was available at 
GenBank, oligonucleotide primers were designed as homologous to 
regions of different exons: steroidogenic acute regulatory (StAR) protein, 
P450 side-chain cleavage (P450scc), 3/3-hydroxysteroid dehydrogenase 
(3/3-HSD), 17/3-hydroxysteroid dehydrogenase (17/3-HSD), 5a-reductase 
isoform 1 (5a-Rl), a-tubulin, CRH, CRH subtype 1 receptor (CRH-R1) 
genes.
PCR products were separated on 2% agarose gels and visualized with 
ethidium bromide. The identity of PCR products was checked by se­
quencing, using a fluorescence-based dideoxy-sequencing reaction and 
an automated sequence analysis on an ABI model 373A DNA sequencer 
(Agowa GmbH, Berlin, Germany).
Commercial cDNA from reverse transcribed human brain mRNA 
(Clontech), hamster brain tissue, rat pituitary tissue, and rat GH ade­
noma cell line GH3 (35) were also employed as positive controls.
Androgens assay
Determinations of testosterone and androstane-3a,l7/3-diol (3a-Diol) 
levels in the incubation media were carried out by RIA without extrac­
tion using antibodies obtained from Immunotech Diagnostic (Montreal, 
Canada). A specific antibody to 3a-diol-l5-CMO-BSA showing 5% cross­
reaction with testosterone was used according to the method described 
by Frungieri et al. (36). Testosterone was measured using an antibody to 
testosterone-7a-butyrate-BSA that is known to have 35% cross-reactivity 
with dihydrotestosterone (DHT). The minimum detectable assay con­
centrations were 0.215 pmol/ml for testosterone and 0.105 pmol/ml for 
3a-Diol. Intraassay coefficient of variation was less than 12% for tes­
tosterone and less than 15% for 3a-Diol, and interassay coefficient of 
variation was less than 15% for each of these two steroids.
bi vitro testosterone and 3a-Diol production from Leydig cells have 
been expressed in terms of picomoles per 106 Leydig cells.
cAMP assay
Determinations of cAMP levels in the incubation media were carried 
out by RIA according to the method described by Del Punta et al. (37) 
and validated by Frungieri et al. (32). 2'-O-Monosuccinyladenosine- 
3',5'-cyclic monophosphate tyrosyl methyl ester (TME-cAMP) was pur­
chased from Sigma. TME-cAMP was radiolabeled with Na125I (DuPont 
NEN Life Science Products, Boston, MA) in our laboratory by the 
method of chloramine T (specific activity, 600 Ci/mmol) described by 
Birnbaumer (38). Specific antibody for cAMP was a gift from Dr. A. F. 
Parlow and the National Hormone and Pituitary Program (National 
Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, 
MD).
Samples and standards were acetylated before the assay to increase 
sensitivity of detection (39). Under these conditions, the standard curve 
was linear between 0.125 and 20 pmol/ml. Intra- and interassay coef­
ficients of variation were less than 8% and less than 10%, respectively.
bi vitro cAMP production from Leydig cells has been expressed as 
picomoles per 10® Leydig cells.
Immunoblotting
Cells and tissues were homogenized in 62.5 mM Tris-HCl buffer (pH 
6.8) containing 10% sucrose and 2% sodium dodecyl sulfate by sonica­
tion. Samples were heated (95 C for 5 min) under reducing conditions 
(10% mercaptoethanol), loaded on tricine-sodium dodecyl sulfate-poly- 
acrylamide gels (12%), electrophoretically separated, and blotted onto 
nitrocellulose (34). Blots were incubated with rabbit antihuman mella 
receptor antibody (CIDtech Research Inc., Mississauga, Canada, 1:100, 
overnight) in presence or absence of a specific blocking peptide (CIDtech 
Research, 1:200, overnight), and subsequently with peroxidase-labeled 
secondary antibody (donkey antirabbit IgG, 1:1000, Amersham Phar­
macia Biotech AB, Uppsala, Sweden). Signals were detected with an 
enhanced chemiluminescence kit (Amersham Pharmacia Biotech).
CRH assay
Determinations of intracellular CRH levels were carried out by a 
commercial EIA (Peninsula Laboratories) after concentration and ex­
traction through C18 Sep-columns (Peninsula Laboratories). Approxi­
mately 3.0 x 10s Leydig cells were incubated in presence or absence of 
1 /zM melatonin for 3 h, centrifuged at 1,200 x g for 10 min, suspended 
in 10 mM PBS (pH 7.4) containing 2.6 mM EDTA and 10 /-'-g/ml aprotinin, 
sonicated, and centrifuged at 105,000 x g for 1 h. Supernatants were 
injected into a 200-mg C18 column and eluted with 60% acetonitrile in 
1% trifluoroacetic acid. Eluted fractions were evaporated to dryness in 
TABLE 1. Oligonucleotide primers employed for PCR amplification of cDNAs obtained after reverse transcription (RT) from total 
testicular tissue or isolated Leydig cells of adult hamsters




StAR GAGTGGAACCCCAATGTC GCACCATGCAAGTGGGAC 243 56
P450scc GAGTCCCAGCGGTTCAT CCTCCTGCCAGCATCTC 291 54
3/3-HSD TCAATGTGAAAGGTACCC ATCATAGCTTTGGTGAGG 499 51
17/3-HSD CAATGGGACAATGGGCAG GTGTCATCTTGACTACGG 359 54
5a-Rl CAGGAGCTGCCCTCGATG CCTGGTTTTCTCAGATTCC 361 56
3a-HSD AGGCCATGGAGAAGTGTAA CACGCTGCAGCTGGTAG 344 54
a-Tubulin First set GGCAAGGAGATCATTGAC TCTCAGGGAAGCAGTGAT 398 54
Second nested set GTCTCCAGGGCTTCTTG GTCTACCATGAAGGCACA 223 54
mella First set GATGGAATCTGGGATATC CCACGAACAGCCACTCTG 561 55
Second nested set CTGCTACATTTGTCACAG ACCACCACTGCTATCGTG 201 55
mellb First set GCCTCATCTGGCTCCTCA GCAGCTGTTGAAGTAAGC 422 55
Second nested set TATTCCTGCACCTTCATC CGGGCCTGGAGCACCA 131 55
CRH First set AGAAACTCAGAGCCCAAG CATCAGTTTCCTGTTGCTG 720 54
Second hemi-nested set GAATACTTCCTCCGCCTG CATCAGTTTCCTGTTGCTG 362 54
CRH-R1 First set ATCCACTGGAACCTCATCTC GAAAGAGTTGAAGTAGATGAA 590 58
Second hemi-nested set GTTGGTGACAGCTGCCTA GAAAGAGTTGAAGTAGATGAA 483 56
GenBank accession numbers: StAR, U66490; P450scc, AF323965; 3/3-HSD, L38710; 17/3-HSD, AY426534; 5a-Rl, NM_175283, J05035, and 
BT006834; 3a-HSD, NM_003739 and D17310; a-tubulin, M12252; mella, AF061158 and NM_005958; mellb, U57555, NM_005959, and 
AF141863; CRH, NM_031019 and NM_000756; CRH-R1, AY034599 and X72304.
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a centrifugal concentrator and then dried extracted were stored at —20 
C until CRH quantification. The minimum detectable concentration in 
the EIA was 168.2 fmol /ml. Intra- and interassay coefficients of variation 
were less than 8% and less than 11%, respectively. Intracellular CRH 
concentrations were expressed as femtomoles per 106 Leydig cells.
Statistical analysis
Statistical analyses were performed using one-way ANOVA followed 
by Student-Newman-Keuls test or Kruskal-Wallis test for multiple com­
parisons. Data are expressed as the mean ± sem from three independent 
experiments (three to six replicates per experiment) performed on dif­
ferent cell preparations. For semiquantitative RT-PCR studies, bands 
were quantified by densitometry and normalized to a-tubulin house­
keeping gene using IMAGE (Scion Corp., Frederick, MD).
Results
Inhibitory effect of melatonin on in vitro production of 
androgens from freshly isolated hamster Leydig cells
After a 3-h incubation, hCG-stimulated (100 mIU/ml) in 
vitro production of testosterone from LD-Leydig cells was 
significantly inhibited by melatonin within a range of 10 pM 
and 1 pM (Fig. 1A). Whereas, in 16SD-Leydig cells, testos­
terone production in presence of hCG into the incubation 
media remained unaffected by melatonin (Fig. IB), hCG- 
stimulated 3a-Diol production was inhibited by concentra­
tions of melatonin between 100 pM and 1 pM (Fig. 1C).
Basal testosterone production in LD-Leydig cells showed 
a dose-dependent inhibition by melatonin (Fig. 1A). This 
hormone did not alter the production of testosterone and 
3a-Diol from 16SD-Leydig cells in absence of hCG in the 
incubation media (Fig. 1, B and C).
Inhibitory effect of melatonin on gene expression of StAR 
and steroidogenic enzymes in freshly isolated hamster 
Leydig cells
The addition of hCG (100 mIU/ml) to both LD and 16SD 
Leydig cells resulted in an increased expression of StAR, 
P450scc, 3/3-HSD, and 17/3-HSD (Fig. 2).
In hCG-stimulated LD and 16SD Leydig cells, addition of 
1 pM melatonin significantly reduced mRNA levels of StAR, 
P450scc, 3/3-HSD, and 17/3-HSD (Fig. 2). Novel sequence 
information about 17/3-HSD obtained from the analysis of 
hamster Leydig cells (representing five independently de­
rived identical sequences) was submitted to GenBank (ac­
cession no. AY426534). This partial sequence shows 91.3% 
homology with human and 88.9% homology with rat and 
mouse 17/3-HSD at the nucleotide level.
hCG (100 mIU/ml) induced 5a-Rl expression in LD Ley­
dig cells (Fig. 2, left panel), but it did not affect 5a-Rl expres­
sion in 16SD Leydig cells (Fig. 2, right panel). Moreover, 
melatonin markedly inhibited the expression of 5a-Rl in 
hCG-stimulated LD Leydig cells (Fig. 2, left panel), but it 
significantly induced 5a-Rl expression in hCG-stimulated 
16SD Leydig cells (Fig. 2, right panel).
3a-HSD showed a weak expression in LD Leydig cells (Fig. 
2, left panel). Nevertheless, in 16SD Leydig cells, 3a-HSD 
expression was clearly detected in basal conditions and, 
moreover, induced by hCG (Fig. 2, right panel). In addition, 
expression of 3a-HSD in hCG-stimulated 16SD Leydig cells 
was significantly reduced when melatonin was added to the 
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Fig. 1. Inhibitory effect of melatonin on in vitro production of 
androgens from freshly isolated hamster Leydig cells. Effect of 
different concentrations (10 pM to 1 /xm) of melatonin on basal (open 
circles') and maximally hCG-stimulated (closed circles, 100 mIU/ 
ml) testosterone (A and B) and 3a-Diol (C) production in Leydig 
cells isolated from adult hamsters kept in a LD (14 h light, 10 h 
dark) photoperiod (A) and in Leydig cells isolated from adult ham­
sters exposed to 16SD (6 h light, 18 h dark) (B and C). Incubation 
time was 3 h. In line plot graphics, the mean ± sem from three 
independent experiments (five to six replicates per experiment) 
performed on different cell preparations are shown. For each ex­
periment, Leydig cells were isolated from a pool of 24 testes ob­
tained from 12 adult hamsters. Data were analyzed using ANOVA 
followed by the Student-Newman-Keuls test. Where sem lines are 
not present, sem was encompassed by the area of the symbol. *,P < 
0.05, compared with the control group.
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Fig. 2. Inhibitory effect of melatonin on gene expression of StAR and 
steroidogenic enzymes in freshly isolated hamster Leydig cells. 
Ethidium bromide-stained agarose gels showing cDNA fragments 
that, after sequencing, were shown to correspond to the testicular 
StAR protein, P450scc, 3/3-HSD, 17/3-HSD, 5a-Rl, 3a-HSD, and a- 
tubulin, in Leydig cells isolated from adult hamsters kept in LD (14 
h light, 10 h dark) photoperiod (left panel; or exposed to 16SD (6 h 
light, 18 h dark) (right panel;. Incubation time was 30 min. These 
representative ethidium bromide-stained agarose gels show results 
obtained from one of the three experiments that yielded comparable 
results. In all experiments, PCR bands were quantified by densitom- 
etiy. Results are expressed as fold change relative to the control (basal 
conditions), which was assigned a value of 1, and normalized to a- 
tubulin gene. Line plot graphics show the mean ± sem from three 
independent experiments (three replicates per experiment) per­
formed on different cell preparations. For each experiment, Leydig 
cells were isolated from a pool of 24 testes obtained from 12 adult 
hamsters. Data were analyzed using ANOVA followed by the Student- 
Newman-Keuls test. Where sem lines are not present, sem was en­
compassed by the area of the symbol. *,P < 0.05, compared with the 
control group.
The inhibitory action of melatonin on in vitro production 
of cAMP and androgens from freshly isolated hamster 
Leydig cells is reverted by luzindole, a melatonin 
receptor antagonist
In LD Leydig cells treated with 1 gM melatonin, basal and 
hCG-stimulated testosterone productions were decreased in 
42.5% (picomoles per 106 Leydig cells, untreated: 5.97 ± 0.71 
vs. melatonin treated: 3.43 ± 0.49) and 48.5% (picomoles per 
106 Leydig cells, untreated: 106.73 ± 7.82 vs. melatonin treat­
ed: 55.03 ± 1.78), respectively (P < 0.05, Fig. 3A). Both basal 
and maximal hCG-stimulated cAMP productions from LD 
Leydig cells in presence of melatonin into the incubation 
media, were significantly diminished in 45.6% (picomoles 
per 106 Leydig cells, untreated: 16.13 ± 1.23 vs. melatonin 
treated: 8.77 ± 0.74) and 44.6% (picomoles per 106 Leydig 
cells, untreated: 31.95 ± 1.61 vs. melatonin treated: 17.70 ± 
1.29), respectively (P < 0.05, Fig. 3B).
Luzindole (1 gM), a mella/lb receptor antagonist, re­
verted the inhibitory action of melatonin on testosterone and 
cAMP production in LD Leydig cells (Fig. 3, A and B, re­
spectively). Nevertheless, in absence of melatonin in the in­
cubation media, luzindole did not affect testosterone and 
cAMP production (Fig. 3, A and B, respectively).
hCG (100 mlU/ml) - - - - + + + +
Melatonin (1 gM) - + + - - + + -
Luzindole (1 «M) - - + + - • + ♦
LD-adult hamsters
hCG (100 mlU/mi) - - - - + + + +
Melatonin (1 gM) - + + - . + + .
Luzindole (1 gM) • - + + -- + +
Fig. 3. Luzindole, a melatonin receptor antagonist, reverts the in­
hibitory action of melatonin on in vitro production of testosterone and 
cAMP in Leydig cells isolated from hamsters kept in LD photoperiod. 
Effects of melatonin (1 /xm) and luzindole (1 /xm) on basal and max­
imally hCG-stimulated (100 mIU/ml) testosterone (A) and cAMP (B) 
production in Leydig cells isolated from adult hamsters kept in a LD 
(14 h light, 10 h dark) photoperiod. Incubation time was 3 h. Bar plot 
graphics show the mean ± sem from three independent experiments 
(five to six replicates per experiment) performed on different cell 
preparations. For each experiment, Leydig cells were isolated from a 
pool of 24 testes obtained from 12 adult hamsters. Data were analyzed 
using ANOVA followed by the Student-Newman-Keuls test. Where 
sem lines are not present, sem was encompassed by the area of the bar. 
All groups were compared; different letters above the bars denote a 
statistically significant difference between the groups (P < 0.05).
In 16SD Leydig cells treated with melatonin, basal 
and hCGstimulated testosterone production remained un­
changed (Fig. 4A). Moreover, melatonin did not affect the 
levels of 3a-Diol and cAMP secreted to the media in basal 
conditions (Fig. 4, B and C, respectively). In contrast, under 
maximal hCG stimulation, melatonin decreased 3a-Diol and 
cAMP productions from 16SD Leydig cells in 64.5% (pico­
moles per 106 Leydig cells, untreated: 46.26 ± 2.61 vs. mel­
atonin treated: 26.60 ± 0.99) and 42.5% (picomoles per 106 
Leydig cells, untreated: 163.10 ± 1.37 vs. melatonin treated: 
58.32 ± 2.09), respectively (P < 0.05, Fig. 4, B and C, respec­
tively). The inhibitory action of melatonin on hCG-stimu- 
lated cAMP and 3a-Diol production in 16SD Leydig cells was 
blocked by 1 gM luzindole (Fig. 4, B and C, respectively). In 
absence of melatonin into the incubation media, luzindole 
did not affect androgen and cAMP productions (Fig. 4, A-C).
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g 16SD-adult hamsters
hCG (100 mIU/ml) ---- + + + +
Melatonin (1 pM) - + + - - + + -
Luzindole (1 //M) - - + + .. + +
16SD-adult hamsters
hCG (100 mIU/ml) - - - - + + + +
Melatonin (1 yzM) • + + - - + + -
Luzindole (1/¿M) - - + + .. + +
Fig. 4. Luzindole, a melatonin receptor antagonist, reverts the in- 
hibitoiy action of melatonin on in vitro production of 3o-Diol and 
cAMP in Leydig cells isolated from hamsters exposed to 16SD. Effects 
of melatonin (1 /xm) and luzindole (1 /xm) on basal and maximally 
hCG-stimulated (100 mIU/ml) testosterone (A), 3o-Diol (B), and 
cAMP (C) production in Leydig cells isolated from adult hamsters 
exposed to 16SD (8 h light, 16 h dark). Incubation time was 3 h. Bar 
plot graphics show the mean ± sem from three independent experi­
ments (five to six replicates per experiment) performed on different 
cell preparations. For each experiment, Leydig cells were isolated 
from a pool of 24 testes obtained from 12 adult hamsters. Data were 
analyzed using ANOVA followed by the Student-Newman-Keuls test. 
Where sem lines are not present, sem was encompassed by the area 
of the bar. All groups were compared; different letters above the bars 
denote a statistically significant difference between the groups (P < 
0.05).
Identification of mella in testes by RT-PCR and 
immunohistochemistry
Using RT-PCR, we amplified cDNA fragments (201 bp) 
that, after sequencing, were shown to correspond to mella 
receptors from the rat GH adenoma cell line GH3 (positive 
control), a commercial human testicular cDNA, LD adult 
hamster testes, 16SD adult hamster testes, Leydig cells iso­
lated from adult animals maintained under LD conditions, 
and Leydig cells obtained from adult hamsters exposed to 
16SD (Fig. 5A).
Mellb receptors were expressed in all positive control 
samples employed, namely human cDNAs from brain, adult 
hamster brain, and, after a second PCR using nested primers, 
also in GH3 cells (Fig. 5B). However, we did not amplify 
cDNAs corresponding to mellb receptors either in the first 
or second PCR using nested primers in human cDNAs from 
testes, LD hamster testes, 16SD hamster testes, LD hamster 
Leydig cells, or 16SD hamster Leydig cells (Fig. 5B).
When Western blotting analyses using an anti-mella an­
tibody were performed, expected immunoreactive bands at 
approximately 37 kDa were seen in rat adult pituitary (pos­
itive control) and purified LD as well as 16SD hamster Leydig 
cells (Fig. 5C). The identity of these 37-kDa bands was in­
dicated by preadsorption of the antibody with a specific 
blocking peptide (Fig. 5C).





c 2 3 5 yeiia
Fig. 5. RT-PCR and Western blot identification of mella in testes. 
Gene expression analysis of mella (A) and mellb (B) receptor sub­
types in testes. A, Ethidium bromide-stained agarose gels showing 
201-bp cDNA fragments that, after sequencing, were shown to cor­
respond to the Syrian hamster and human mella receptor subtype in 
the suprachiasmatic nuclei. B, Ethidium bromide-stained agarose 
gels showing 422-bp and 131-bp (after second nested PCR) cDNA 
fragments 100% identical with previously identified mellb receptor 
subtype in human brain and retina and in the rat suprachiasmatic 
nuclei. A and B, Lane 1, normal human testes (pooled normal tes­
ticular cDNA); lane 2, rat GH adenoma cell line GH3; lane 3, testes 
from adult hamsters kept in a LD (14 h light, 10 h dark) photoperiod; 
lane 4, testes from adult hamsters exposed to 16SD (6 h light, 18 h 
dark); lane 5, Leydig cells isolated from adult hamsters kept in LD 
photoperiod; lane 6, Leydig cells isolated from adult hamsters exposed 
to 16SD; lane 7, normal human brain (commercial cDNA); and lane 
8, adult hamster brain. C, Western blot analysis of rat pituitary (lane 
1), Leydig cells isolated from adult hamsters kept in LD photoperiod 
(lanes 2 and 3), and Leydig cells isolated from adult hamsters exposed 
tol6SD (lanes 4 and 5) probed with anti-mella without preadsorption 
(lanes 1, 2, and 4) or after preadsorption (lanes 3 and 5) with a specific 
blocking peptide. Anti-mella dilution 1:100, blocking peptide dilution 
1:200, enhanced chemiluminescence method. Fifteen micrograms of 
protein from rat pituitary homogenate (lane 1) and 100 yig protein 
from Leydig cells homogenates (lanes 2-5) were loaded on the gel.
Downloaded from https://academ
ic.oup.eom
/endo/artide-abstract/1 46/3/1541 /250116/ by guest on 23 August 2019
Frungieri et al. • Melatonin in Syrian Hamster Testes Endocrinology, March 2005, 146(3):1541-1552 1547
The inhibitory action of melatonin on maximally hCG- 
stimulated in vitro production of cAMP and androgens from 
freshly isolated hamster Leydig cells is reverted by the 
competitive CRH receptor antagonist a-helical CRH-[9-41] 
but not affected by p-MPPI [a 5-hydroxytryptamine 
(5HT)1a receptor blocker] or ketanserin (a 5HT2A/1C 
receptor blocker)
Both 1 gM CRH and 1 gM melatonin significantly inhibited 
hCG-stimulated androgen and cAMP productions in both 
LD Leydig cells (Fig. 6, A and B) and 16SD Leydig cells (Fig. 
6, C and D).
a-Helical CRH-[9-41], a competitive CRH receptor antag­
onist, reverted the inhibitory action of CRH on hCG-induced 
production of testosterone and cAMP from LD hamster Ley­
dig cells (Fig. 6, A and B). Moreover, a-helical CRH-[9-41] 
also blocked the modulatory action of CRH on hCG-induced 
production of 3a-Diol and cAMP from 16SD hamster Leydig 
cells (Fig. 6, C and D). The inhibitory effect of melatonin on 
hCG-stimulated testosterone and cAMP production from LD 
hamster Leydig cells (Fig. 6, A and B) as well as the pro­
duction of 3a-Diol and cAMP from 16SD hamster Leydig 
cells (Fig. 6, C and D) was also reverted in presence of 
a-helical CRH-[9-41] in the incubation media. Nevertheless, 
incubation of hamster Leydig cells with a-helical CRH-[9- 
41] in absence of CRH and melatonin did not affect andro­
gens and cAMP production (Fig. 6, A-D).
We have already shown that hamster Leydig cells contain 
the serotoninergic receptors 5HT1A and 5HT2 (32). The in­
hibitory action of serotonin and (±) 8-hydroxy-2(Dl-N-pro- 
pylamino) tetralin hydrobromide (a 5HT1A receptor agonist) 
on hCG-stimulated testosterone production from hamster 
Leydig cells is respectively partially and totally reverted by
p-MPPI, a specific antagonist of 5HT1A receptors (32). More­
over, ketanserin (5HT2A/iC receptor antagonist) partially re­
verts the inhibitory effect of serotonin and totally blocks the 
negative action of (±)l-[2,5-dimethoxy-4-iodophyryl]-2- 
amino propane hydrochloride (a 5HT2/1C receptor agonist) 
on androgen production from hamster Leydig cells (32). In 
the present study, we analyzed whether the addition of p- 
MPPI and ketanserin into the incubation media of hamster 
Leydig cells alters the negative modulation of melatonin on 
androgen production. Both p-MPPI and ketanserin failed to 
revert the inhibitory action of melatonin on androgen pro­
duction under hCG-stimulated conditions (data not shown).
Identification of CRH and CRH-R1 in testes: stimulatory 
effect of melatonin on mRNA levels and intracellular 
concentration of CRH in hamster Leydig cells
We detected mRNA expression of CRH and CRH-R1 in LD 
adult hamster testes, 16SD adult hamster testes, and Leydig 
cells isolated from adult animals maintained under LD con­
ditions or exposed to a 16SD (Fig. 7A). Moreover, CRH and 
CRH-R1 were also expressed in commercial human testicular 
cDNAs (Fig. 7A).
Melatonin significantly induced mRNA expression of 
CRH in basal and hCG maximally stimulated LD hamster 
Leydig cells (Fig. 7B).
Under hCG-stimulated conditions, melatonin also up- 
regulated CRH expression in 16SD Leydig cells (Fig. 7C). 
Nevertheless, in absence of hCG in the media, mRNA CRH 
levels remained unaffected by melatonin in 16SD hamster 
Leydig cells (Fig. 7C).
Moreover, melatonin increased intracellular CRH concen-
Fig. 6. The competitive CRH receptor 
antagonist a-helical CRH-19-41] re­
verts the inhibitory effect of CRH and 
melatonin on maximally hCG-stimu- 
lated in vitro production of cAMP and 
androgens from freshly isolated ham­
ster Leydig cells. Effect of 1 g.M a-helical 
CRH-19-41] on maximally hCG-stimu- 
lated(100 mIU/ml) testosterone (A), 3 a- 
Diol (C), and cAMP (B and D) produc­
tion from LD hamster (A and B, upper 
panels') and 16SD hamster (C and D, 
bottom panels') Leydig cells in presence 
of 1 g.M CRH or 1 g.M melatonin. Incu­
bation time was 3 h. Bar plot graphics 
show the mean ± sem from three inde­
pendent experiments (five to six repli­
cates per experiment) performed on 
different cell preparations. For each 
experiment, Leydig cells were isolated 
from a pool of 24 testes obtained from 
12 adult hamsters. Data were analyzed 
using ANOVA followed by the Student- 
Newman-Keuls test. Where sem lines 
are not present, sem was encompassed 
by the area of the bar. All groups were 
compared; different letters above the 
bars denote a statistically significant 
difference between the groups (P < 
0.05).










hCG (100 mIU/ml) 0
Melatonin (1 /;M)







+ . + +
CRF antagonist (1 pM) - - - + - + +
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Fig. 7. RT-PCR identification of CRH and CRH-R1 in testes. Stim­
ulatory effect of melatonin on mRNA levels and intracellular concen­
tration of CRH in hamster Leydig cells. A, Gene expression analysis 
of CRH and CRH-R1 in testes. Ethidium bromide-stained agarose gel 
showing cDNA fragments that, after sequencing, were shown to cor­
respond to the brain CRH and CRH-R1. Lane 1, Testes from adult 
hamsters kept in a LD ( 14 h light, 10 h dark) photoperiod; lane 2, testes 
from adult hamsters exposed to 16SD (6 h light, 18 h dark); lane 3, 
normal human testes (pooled normal testicular cDNA); lane 4, Leydig 
cells isolated from adult hamsters kept in LD photoperiod; and lane 
5, Leydig cells isolated from adult hamsters exposed to 16SD. B and 
C, Effect of 1 g.M melatonin on basal and hCG-stimulated (100 mIU/ 
ml) gene expression of CRH in LD hamster Leydig cells (B) and 16SD 
hamster Leydig cells (C). Incubation time was 30 min. These repre­
sentative ethidium bromide-stained agarose gels show results ob­
tained from one of the three experiments that yielded comparable 
results. In all experiments, PCR bands were quantified by densitom- 
etiy. Results are expressed as fold change relative to the control (basal 
conditions), which was assigned a value of 1, and normalized to a- 
tubulin gene. Bar plot graphics show the mean ± sem from three 
tration in basal LD Leydig cells but showed no effect in basal 
16SD Leydig cells (Fig. 7D).
Discussion
Our studies provide evidence for the existence of a me- 
latonergic system in the testis. This testicular melatonergic 
system, working in concert with the primary effect of mel­
atonin on the hypothalamic-pituitary axis, may thus act as 
local modulator of steroidogenesis in the seasonal breeder 
Syrian hamster. The previously unknown signaling pathway 
associated to the effect of melatonin on testicular activity 
involves down-regulation of StAR and key steroidogenic 
enzymes (P450scc, 3/3-HSD, and 17/3-HSD) expression lead­
ing to inhibition of the hCG-stimulated cAMP and androgen 
production. Furthermore, our results indicate that acting 
through specific mella receptors located in Leydig cells and 
interacting with the testicular CRH system, melatonin may 
represent an as-yet-unrecognized local inhibitory control of 
the testicular function.
Melatonin synthesis in the pineal gland involves the con­
version of serotonin into melatonin by modulation of the 
activity of its biosynthetic enzymes: serotonin N-acetyltrans- 
ferase and hydroxyindole-O-methyltransferase (40). Newly 
synthesized melatonin passively diffuses from pinealocytes 
into the blood almost entirely at night (15). Particularly for 
Syrian hamsters, circulating melatonin shows a clear circa­
dian rhythm reaching peak levels (—130 pM) several hours 
after lights off. Then circulating melatonin concentration be­
gins to fall and reaches daytime levels after lights on (—43 
pM) (15, 41).
It has been already determined that pineal-derived mel­
atonin in circulation is taken up by peripheral tissues in­
cluding the testes (13-15, 42, 43). In addition to this pineal 
source, the ability of the testes to locally synthesize melatonin 
has also been demonstrated in a nonphotoperiodic mammal 
(rat) and a bird (quail) (16-19). The important role played by 
melatonin in the regulation of the reproductive activity in 
seasonal breeders has been known for a long time (43). Con­
comitantly with the already described action of melatonin on 
the hypothalamus and the pituitary, and in accordance with 
initial reports from Valenti et al. (22) for rat testis, we detected 
that physiological concentrations of melatonin exert a direct 
inhibitory effect on hCG-stimulated cAMP and androgen 
production from purified LD and 16SD hamster Leydig cells.
independent experiments (three replicates per experiment) per­
formed on different cell preparations. For each experiment, Leydig 
cells were isolated from a pool of 24 testes obtained from 12 adult 
hamsters. Data were analyzed using ANOVA followed by the Student- 
Newman-Keuls test. Where sem lines are not present, sem was en­
compassed by the area of the bar. *, P < 0.05, compared with the 
control group. D, Effect of 1 g.M melatonin on intracellular CRH 
concentration in basal LD and 16SD hamster Leydig cells (D). Incu­
bation time was 3 h. Bar plot graphics show the mean ± sem from 
three independent experiments (three replicates per experiment) per­
formed on different cell preparations. For each experiment, Leydig 
cells were isolated from a pool of 24 testes obtained from 12 adult 
hamsters. Data were analyzed using ANOVA followed by the Student- 
Newman-Keuls test. Where sem lines are not present, sem was en­
compassed by the area of the bar. All groups were compared; different 
letters above the bars denote a statistically significant difference be­
tween the groups (P < 0.05).
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Therefore, these results point out the potential relevance of 
melatonin in the local modulation of androgen production. 
Whereas melatonin reduced basal and hCG-stimulated tes­
tosterone production from LD hamster Leydig cells, it did 
not alter testosterone secretion from 16SD hamster Leydig 
cells. However, in 16SD hamster Leydig cells, melatonin 
significantly diminished hCG-stimulated 3a-Diol produc­
tion but showed no effect on basal 3a-Diol secretion into the 
incubation media. Previous observations made by our group 
and other authors indicated that for hamsters, testicular and 
circulating levels of androgens (testosterone, DHT, 3a-Diol) 
are markedly reduced during the regression period (26-29). 
Nevertheless, inactive adult hamster testes release more Sa- 
reduced compounds (DHT + 3a-Diol) than active adult ham­
ster testes, 3a-Diol being the main androgen produced from 
regressed testes under in vitro conditions (44). Employing 
semiquantitative RT-PCR we found that melatonin reduces 
the expression of StAR protein and important steroidogenic 
enzymes: P450scc, 3/3-HSD, and 17/3-HSD in both LD and 
16SD hamster Leydig cells.
Our results are supported by previous publications re­
porting a melatonergic inhibition of StAR expression in 
MA-10 mouse Leydig tumor cells (45), and 17-20 desmolase 
enzymatic activity in rat Leydig cells (46). Moreover, adult 
rats injected with melatonin show a significant decrease in 
their testicular activity of 3/3-HSD and 17/3-HSD (47). In LD 
Leydig cells melatonin clearly inhibits mRNA expression of 
5a-Rl, an enzymatic isoform that plays a crucial role for the 
testicular conversion of testosterone into the active and non- 
aromatizable testosterone metabolite DHT (48). Neverthe­
less, 5a-Rl is significantly induced in melatonin-treated 
16SD Leydig cells.
In this context, we previously described that 5a-reductase 
activity is markedly increased in 16SD hamster testes when 
compared with LD hamster testes (44), and 16SD hamster 
Leydig cells produce more DHT than LD hamster Leydig 
cells (44). Thus, in SD hamster testes, melatonin stimulates 
the conversion of testosterone into 5a-reduced androgens via 
5a-Rl induction. On the other hand, in LD Leydig cells, 
3a-HSD (an enzyme that catalyzes the interconversion be­
tween DHT and 3a-Diol) shows a weak expression after 40 
PCR cycles but, in 16SD Leydig cells, 3a-HSD is easily de­
tectable in both basal and hCG-stimulated conditions. Ji et al. 
(49) recently demonstrated that 3a-HSD expression is in­
creased by DHT treatment in a prostate cancer cell line. 
Furthermore, we detected that 3a-HSD expression is signif­
icantly reduced in the presence of melatonin into the incu­
bation media of hCG-treated 16SD Leydig cells. Conse­
quently, in SD hamster testes, DHT and 3a-Diol productions 
are controlled by melatonin via induction of 5a-Rl and in­
hibition of 3a-HSD.
The present results indicate that melatonin exerts an in­
hibitory action on hCG-stimulated androgen production in 
hamster testes. Moreover, in 16SD hamster Leydig cells mel­
atonin shows an additional role inducing the conversion of 
non-5a-reduced into 5a-reduced androgens and subse­
quently modulating the production of the main androgen 
3a-Diol.
Testosterone production from Leydig cells is stimulated by 
not only LH, which is the primary messenger and activates 
the cAMP pathway, but also by several endocrine and para­
crine factors, which can act through non-cAMP-dependent 
pathways including GnRH (50). Valenti et al. (51) previously 
reported that melatonin also participates in the regulation of 
GnRH-induced testosterone secretion in adult rat Leydig 
cells cultured in vitro.
Other well-known functions of melatonin could addition­
ally participate in the regulation of testicular activity. For 
instance, numerous in vitro and in vivo studies documented 
the ability of both physiological and pharmacological con­
centrations of melatonin to protect against free radical de­
struction and, consequently, to modulate cellular prolifera­
tion and differentiation (52, 53).
To our knowledge, characterization of melatonin receptors 
in testes has been exclusively assayed by 2-[125I]iodomela- 
tonin-binding studies (23-25, 46). Pharmacological assays 
and binding capability to radioligand studies performed 
were unable to discriminate among different subtypes of 
melatonin receptors (54,55). In the present study, we initially 
employed luzindole, a high-affinity melatonin receptor an­
tagonist that binds to both mella and mellb sites, albeit with 
different affinities (5). Luzindole reverted the inhibitory ac­
tion of melatonin on cAMP and androgen production from 
LD and 16SD hamster Leydig cells. Further experiments 
using RT-PCR and Western blot techniques allowed us to 
characterize the presence of mella but not mellb sites in both 
LD and 16SD hamster testes. Mella receptor subtype is ex­
pressed in the suprachiasmatic nucleus of the hypothalamus 
and pars tuberalis of the pituitary (6, 7), but it has been also 
detected in several peripheral reproductive tissues including 
placenta, prostate, epididymis, and ovary (56-59). Because 
the expression of mellb receptors was not detected in ham­
ster Leydig cell membranes, we could assume that the me­
latonergic modulation of steroidogenesis reverted by the 
melatonin receptor antagonist luzindole takes place through 
the binding of melatonin to mella receptors.
In the central nervous system, in vivo and / or in vitro stud­
ies have described cross-interactions between the melaton­
ergic and serotonergic systems (60-66), which could take 
place at receptor and/or second messenger levels. In the 
testis, our group as well as other authors has described the 
existence of interactions between the inhibitory serotonergic 
and CRH systems involved in the modulation of androgen 
production in rat (31) and Syrian hamster (32). Because se­
rotonin is the limiting substrate in the biosynthesis of mel­
atonin (1) and, in an attempt to establish interactions between 
the melatonergic system and other well-described testicular 
regulatory systems, we analyzed the effect of CRH, 5HT1A 
and 5HT2A receptor antagonists on the modulatory action of 
melatonin at gonadal level. The 5HT1A antagonist, p-MPPI, 
as well as the 5HT2A/iC antagonist, ketanserin, failed to re­
vert the inhibitory melatonergic regulation on hCG-stimu- 
lated androgen production, suggesting that testicular 5HT1A 
and 5HT2A receptors do not interact with the testicular mel­
atonin system. Unexpectedly, the competitive CRH receptor 
antagonist, a-helical CRH (9-41), blocked the inhibitory ef­
fect of melatonin on hCG-stimulated cAMP and androgen 
production in both LD and 16SD hamster Leydig cells, sug­
gesting that melatonin effect on steroidogenesis could take 
place through the local CRH system.
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It has been described that in mouse Leydig cells, CRH 
directly stimulated basal testosterone production but did not 
influence the maximum hCG-induced testosterone produc­
tion (67). Controversial findings about CRH effect on rat 
Leydig cells have been reported. Fabbri et al. (30) and Dufau 
et al. (31) described CRH as a negative modulator of hCG- 
stimulated testicular steroidogenesis in rats. Nevertheless, 
no influence of CRH on the basal and hCG-stimulated tes­
tosterone production from rat Leydig cells was observed by 
Heinrich et al. (67). In this work, we described an inhibitory 
effect of CRH on gonadotropin-induced cAMP and androgen 
production in both LD and 16SD hamster Leydig cells. More­
over, in hamster Leydig cells, we found expression of 
CRH-R1 and the presence of intracellular CRH at mRNA and 
protein levels. These observations agree with previous re­
ports indicating CRH secretion from rat Leydig cells (30,31) 
and the existence of CRH-R1 in mouse and rat testes (67, 68).
When LD Leydig cells were incubated in presence of mel­
atonin, we detected the up-regulation of mRNA CRH ex­
pression in both basal and hCG-stimulated conditions. Nev­
ertheless, in 16SD Leydig cells, melatonin induced mRNA 
CRH expression exclusively when hCG was added into the 
incubation media. Subsequent determination of CRH con­
centration in hamster Leydig cells by a commercial EIA ver­
ified the semiquantitative RT-PCR results achieved under 
basal conditions. Unfortunately, because hCG induces the 
secretion of CRH to the media (31), intracellular peptide 
levels in hCG-stimulated Leydig cells were out of the de­
tection limit of our EIA.
Under basal conditions, CRH concentration in 16SD ham­
ster Leydig cells was unaffected by melatonin but doubled if 
compared with untreated LD hamster Leydig cells and sim­
ilar to those detected in melatonin-treated LD hamster Ley­
dig cells. These results let us speculate that Leydig cells of 
regressed adult hamsters exposed to light deprivation and 
extended night melatonin secretion from pineal gland into 
circulation (40, 41) are already challenged to produce a 
higher amount of CRH than those synthesized from control 
LD Leydig cells.
Taken together, these data indicate that the effect of mel­
atonin on steroidogenesis involves the interaction between 
the melatonergic system and the local CRH system. Thus, 
melatonin stimulates CRH production from Leydig cells and 
its subsequent inhibitory action on hCG-stimulated andro­
gen production. New studies are in progress to gain more 
insight into the mechanisms related to the interaction be­
tween the testicular melatonergic and CRH systems leading 
to regulation of steroidogenesis, e.g. modulation of receptors 
number, changes in the level and / or activity of signaling 
pathways components, induction/repression of specific 
genes expression.
In seasonal breeders, testicular activity results from the 
gonadotropic effect of the pineal-derived melatonin secreted 
during darkness mainly by acting at the level of the brain and 
pituitary. The nature of the photoperiodic message that 
reaches the retina (i.e. pro- or antigonadotropic) depends on 
the species (LD, SD, or nonseasonal breeders), daylight vari­
ations and their consequences on the duration and magni­
tude of nightly elevated melatonin, and/or the period of 
sensitivity of the reproductive system to melatonin (13). In 
addition to this central melatonergic regulatory mechanism, 
the present study describes a potential local effect of mela­
tonin on the testis that could work in concert enhancing/ 
antagonizing the primary effect of this hormone on testicular 
activity through the hypothalamic-pituitary axis. In the Syr­
ian hamster, specific mella receptors were located in Leydig 
cells and down-regulation of the gene expression of StAR 
protein and key steroidogenic enzymes P450scc, 3/3-HSD, 
and 17/3-HSD by melatonin was shown. Moreover, interac­
tions between the testicular melatonergic and CRH systems 
were described.
In conclusion, our current findings have demonstrated the 
existence of a melatonergic system in the Syrian hamster 
testis and have established the biological basis and possible 
physiological implications of this system as local modulator 
of the testicular hCG-stimulated cAMP and androgen pro­
duction. Nevertheless, previous reports have indicated that 
melatonin directs its effects on the testes through the hypo- 
thalamic-pituitary axis and not directly at the gonadal level 
(2, 4, 69, 70). Thus, more studies are required before the 
biological relevance of our results and, consequently, the role 
of local action of melatonin in the hamster testes can be 
placed in its proper perspective. We have also identified the 
expression of all components of the melatonergic system 
(mella, CRH, CRH-R1) in cDNAs from normal human testes 
but whether the inhibitory action of melatonin in the testis of 
the LD seasonal breeder Syrian hamster can be extended to 
nonseasonal reproductive mammalian species including 
man remains to be clarified.
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